Our Indication Assessment service helps pharmaceutical companies evaluate and prioritize therapeutic area opportunities. We combine disease burden analysis, treatment landscape mapping, and unmet need quantification to identify the most promising indications for your assets.
How our indication assessment service delivers value to your organization.
Rigorous assessment of treatment gaps with patient-level analysis of unmet need severity and commercial potential.
Comprehensive epidemiological models covering incidence, prevalence, mortality, and disease progression.
Detailed mapping of current treatment algorithms, prescribing patterns, and physician decision drivers.
Analysis of biomarker prevalence and companion diagnostic opportunities for targeted therapies.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Build comprehensive disease burden models with incidence, prevalence, and patient segmentation.
Map current treatment algorithms, standard of care, and physician prescribing drivers.
Quantify unmet need with patient-level analysis of treatment gaps and outcome limitations.
Score the indication opportunity on commercial potential, development risk, and strategic fit.
We use a multi-factor approach combining treatment gap analysis, outcome data, physician survey insights, and patient-reported outcomes to generate a quantitative unmet need score.
Yes, we can run parallel indication assessments with comparative scoring to help you prioritize across multiple opportunities.
Yes, we incorporate real-world evidence from claims data, registries, and electronic health records to validate our treatment landscape analysis.
Detailed market sizing, forecasting, and competitor positioning to identify white space and launch opportunities.
Learn moreTrack global drug pipelines across 190+ markets with phase progression analysis, competitive landscaping, and predictive scoring.
Learn moreData-driven asset valuation and portfolio optimization using clinical, commercial, and regulatory risk scoring.
Learn moreConnect with our team to discuss how our indication assessment service can support your goals.
Schedule a Consultation